211 related articles for article (PubMed ID: 25650721)
1. Macrocycles as potential therapeutic agents in neglected diseases.
Peña S; Scarone L; Serra G
Future Med Chem; 2015; 7(3):355-82. PubMed ID: 25650721
[TBL] [Abstract][Full Text] [Related]
2. Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates.
Cavalli A; Lizzi F; Bongarzone S; Belluti F; Piazzi L; Bolognesi ML
FEMS Immunol Med Microbiol; 2010 Feb; 58(1):51-60. PubMed ID: 19845762
[TBL] [Abstract][Full Text] [Related]
3. Drug discovery and human African trypanosomiasis: a disease less neglected?
Ferrins L; Rahmani R; Baell JB
Future Med Chem; 2013 Oct; 5(15):1801-41. PubMed ID: 24144414
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
5. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
Werbovetz K
Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
[TBL] [Abstract][Full Text] [Related]
6. Natural Products as a Source for Antileishmanial and Antitrypanosomal Agents.
Scotti MT; Scotti L; Ishiki H; Ribeiro FF; Cruz RM; Oliveira MP; Mendonça FJ
Comb Chem High Throughput Screen; 2016; 19(7):537-53. PubMed ID: 27682867
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
[TBL] [Abstract][Full Text] [Related]
8. Privileged Structures in the Design of Potential Drug Candidates for Neglected Diseases.
Leite ACL; Espíndola JWP; de Oliveira Cardoso MV; de Oliveira Filho GB
Curr Med Chem; 2019; 26(23):4323-4354. PubMed ID: 29065822
[TBL] [Abstract][Full Text] [Related]
9. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
Bilbe G
Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
[No Abstract] [Full Text] [Related]
10. Future treatment options for human African trypanosomiasis.
Jones AJ; Avery VM
Expert Rev Anti Infect Ther; 2015; 13(12):1429-32. PubMed ID: 26414688
[TBL] [Abstract][Full Text] [Related]
11. Trends in research of antitrypanosomal agents among synthetic heterocycles.
Kryshchyshyn A; Kaminskyy D; Grellier P; Lesyk R
Eur J Med Chem; 2014 Oct; 85():51-64. PubMed ID: 25072876
[TBL] [Abstract][Full Text] [Related]
12. π-Delocalized Lipophilic Cations as New Candidates for Antimalarial, Antitrypanosomal and Antileishmanial Agents: Synthesis, Evaluation of Antiprotozoal Potency, and Insight into Their Action Mechanisms.
Takasu K
Chem Pharm Bull (Tokyo); 2016; 64(7):656-67. PubMed ID: 27373622
[TBL] [Abstract][Full Text] [Related]
13. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II.
Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
Curr Med Chem; 2012; 19(14):2176-228. PubMed ID: 22414104
[TBL] [Abstract][Full Text] [Related]
14. The Role of Nitro (NO
Kamdem BP; Elizabeth FI
Curr Drug Targets; 2021; 22(4):379-398. PubMed ID: 33371845
[TBL] [Abstract][Full Text] [Related]
15. Lead discovery and optimization strategies for peptide macrocycles.
Bhat A; Roberts LR; Dwyer JJ
Eur J Med Chem; 2015 Apr; 94():471-9. PubMed ID: 25109255
[TBL] [Abstract][Full Text] [Related]
16. Do we need new drugs against human African trypanosomiasis?
Stich A; Ponte-Sucre A; Holzgrabe U
Lancet Infect Dis; 2013 Sep; 13(9):733-4. PubMed ID: 23969207
[No Abstract] [Full Text] [Related]
17. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
[TBL] [Abstract][Full Text] [Related]
18. Drug design for neglected disease in Brazil.
Giarolla J; Ferreira EI
Mini Rev Med Chem; 2015; 15(3):220-42. PubMed ID: 25769971
[TBL] [Abstract][Full Text] [Related]
19. Infectious diseases. Drug developers finally take aim at a neglected disease.
Leslie M
Science; 2011 Aug; 333(6045):933-5. PubMed ID: 21852468
[No Abstract] [Full Text] [Related]
20. Foreword. Trypanosomatid disease drug discovery and target identification.
N Setzer W
Future Med Chem; 2013 Oct; 5(15):1703-4. PubMed ID: 24144406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
